Concepedia

Adam Frymoyer

AF

Statistics

Publications

55

Citations

2.3K

H-Index

29

Active since

2003

Affiliations

Stanford University(Current)

University of California, San Francisco

Stanford Medicine

University of Utah

Palo Alto University

Adam Frymoyer is an author at Stanford University specializing in pharmacology, pharmacy, and pharmacokinetics.

ORCID

Publications per year

2003–2025

55

Publications

55

Prevalence of Acid-Reducing Agents (ARA) in Cancer Populations and ARA Drug–Drug Interaction Potential for Molecular Targeted Agents in Clinical Development

Gillian S. Smelick, Timothy P. Heffron, Laura Chu et al. · Molecular Pharmaceutics · 2013 · 188 citations

, , +14

Current Recommended Dosing of Vancomycin for Children With Invasive Methicillin-Resistant Staphylococcus aureus Infections Is Inadequate

Adam Frymoyer, Adam L. Hersh, Leslie Z. Benet et al. · The Pediatric Infectious Disease Journal · 2009 · 148 citations

, , +17

Association between Vancomycin Trough Concentration and Area under the Concentration-Time Curve in Neonates

Adam Frymoyer, Adam L. Hersh, Mohammed H. Elkomy et al. · Antimicrobial Agents and Chemotherapy · 2014 · 144 citations · Full text

, , +17

Desired Vancomycin Trough Serum Concentration for Treating Invasive Methicillin-resistant Staphylococcal Infections

Adam Frymoyer, B. Joseph Guglielmo, Adam L. Hersh · The Pediatric Infectious Disease Journal · 2013 · 136 citations

, , +17

Model‐Informed Precision Dosing at the Bedside: Scientific Challenges and Opportunities

Ron J. Keizer, Rob ter Heine, Adam Frymoyer et al. · CPT Pharmacometrics & Systems Pharmacology · 2018 · 119 citations · Full text

, , +14

1–5 of 55